发明名称 OPHTHALMIC COMPOSITION
摘要 PROBLEM TO BE SOLVED: To provide an ophthalmic composition having improved effects on asthenopia caused by overuse of eyes such as video display terminal (VDT) operation or psychic tension, and further an ophthalmic composition having high respiratory activating actions on ophthalmic tissues. SOLUTION: This ophthalmic composition comprises xanthines (caffeine, theophylline, theobromine, proxyphylline, pentoxyphylline, etc.), and aspartic acid or its salt. Thereby, the asthenopia can be ameliorated. Furthermore, the composition comprises the xanthines (caffeine, theophylline, theobromine, proxyphylline, pentoxyphylline, etc.), and the aspartic acid or its salt. Thereby, ophthalmic tissue respiration can be activated.
申请公布号 JP2003128553(A) 申请公布日期 2003.05.08
申请号 JP20010401809 申请日期 2001.12.28
申请人 ROHTO PHARMACEUT CO LTD 发明人 INOUE SHU;NITTA HIROO
分类号 A61K31/522;A61K31/198;A61P27/02;(IPC1-7):A61K31/522 主分类号 A61K31/522
代理机构 代理人
主权项
地址